TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -3 | 11 | -4 | -8 | -25 | -5 |
| S | %wins | 100 | 100 | 0 | 50 | 50 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/04 15:30 | 5/4/04 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Schiavo Jacqueline J | CA | O | EVP,Tech | M.d | 3,018 | 38.46 | 33 | 78 | 24 | D | 47 | 8 | -8 | -22 | -18 | -15 | -16 | 1 | -1 | -3 | 3 | -26 | -23 | -17 | |
5/6/04 15:30 | 5/4/04 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Schiavo Jacqueline J | CA | O | EVP,Tech | S.d | -6,950 | 88.57 | 33 | -78 | -77 | 24 | D | 47 | 8 | -8 | -22 | -18 | -15 | -16 | 1 | -1 | -3 | 3 | -26 | -23 | -17 |
10/28/03 18:51 | 10/24/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Schiavo Jacqueline J | CA | O | EVP,Tech | M.d | 275 | 13.01 | 26 | 21 | 887 | 24 | D | -16 | 57 | 40 | 1 | -9 | -3 | -3 | 1 | -3 | -2 | 18 | 18 | 7 | -32 |
10/28/03 18:51 | 10/24/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Schiavo Jacqueline J | CA | O | EVP,Tech | S.d | -1,623 | 76.65 | 26 | -21 | -47 | 24 | D | -16 | 57 | 40 | 1 | -9 | -3 | -3 | 1 | -3 | -2 | 18 | 18 | 7 | -32 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |